Your new experience awaits. Try the new design now and help us make it even better

ORIGINAL RESEARCH article

Front. Cell. Neurosci.

Sec. Cellular Neuropathology

Volume 19 - 2025 | doi: 10.3389/fncel.2025.1685800

Neuroprotection of IGF-1 in neonatal hypoxic-ischemic brain injury through downregulation of FoXO3a-PUMA pathway

Provisionally accepted
Yanli  TangYanli Tang1Rui  ZhongRui Zhong2Jiayi  LiangJiayi Liang2Shuang  LiuShuang Liu2Wanxia  LiuWanxia Liu2TAO  LIUTAO LIU2Baohong  YuanBaohong Yuan2Mengya  JiaoMengya Jiao3Hui  YinHui Yin2*
  • 1Longgang District Maternity & Child Healthcare Hospital of Shenzhen City, Shenzhen, China
  • 2Guangdong Pharmaceutical University, Guangzhou, China
  • 3Jiangxi Provincial People's Hospital, Nanchang, China

The final, formatted version of the article will be published soon.

Insulin-like growth factor-1 (IGF-1) is a single chain polypeptide hormone that plays an essential role in intrauterine and postnatal growth. Recent studies suggest that IGF-1 and its receptor IGF-1R are involved in the pathogenesis of neurological diseases. Here, we explore the effect of IGF-1 signaling in neonatal hypoxic-ischemic (HI) brain injury and elucidate the underlying mechanisms of action. We found that the expression levels of IGF-1 were markedly enhanced in astrocytes post HI. Delivery of IGF-1 significantly alleviates neonatal brain insult and improves neurobehavioral disorders in neonatal mice after HI challenge. Through binding to IGF-1 receptor (IGF-1R), IGF-1 inhibited the apoptosis of neuronal cells following HI exposure. IGF-1 improved neuronal cell survival and proliferation through activation of phosphorylated AKT signaling. Of note, the protective property of IGF-1 against ischemic neuronal insults was dependent on suppression of the FoXO3a-PUMA signaling pathway. Taken together, these findings suggest that IGF-1 may represent a new neuroprotectant for newborns with hypoxic-ischemic encephalopathy.

Keywords: IGF-1, Neonatal hypoxic-ischemic encephalopathy, Neuroprotection, FoxO3a, Puma

Received: 14 Aug 2025; Accepted: 21 Oct 2025.

Copyright: © 2025 Tang, Zhong, Liang, Liu, Liu, LIU, Yuan, Jiao and Yin. This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) or licensor are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.

* Correspondence: Hui Yin, huiyin0103@163.com

Disclaimer: All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.